Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kadereit, S.
Right arrow Articles by Laughlin, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kadereit, S.
Right arrow Articles by Laughlin, M. J.

Stem Cells 2002;20:573-582 www.StemCells.com
© 2002 AlphaMed Press

Expansion of LTC-ICs and Maintenance of p21 and BCL-2 Expression in Cord Blood CD34+/CD38- Early Progenitors Cultured over Human MSCs as a Feeder Layer

Suzanne Kadereita, Linda S. Deedsa, Stephen E. Haynesworthb, Omer N. Koca,c, Margaret M. Kozika, Emese Szekelyc, Kathleen Daum-Woodsc, Glenn W. Goetchiusa, Pingfu Fud, Lisbeth A. Welniake, William J. Murphye, Mary J. Laughlina

a Department of Medicine,
b Department of Biology,
c NCI Comprehensive Cancer Center,
d Department of Epidemiology and Biostatistics, Case Western Reserve University/University Hospitals of Cleveland, Cleveland, Ohio, USA;
e SAIC Frederick, NCI at Frederick, Frederick, Maryland, USA

Key Words. UCB • Expansion • Hematopoietic progenitors • Mesenchymal stem cells

Mary J. Laughlin, M.D., Director, Allogeneic Transplant Program, Case Western Reserve University, University Hospitals Ireland Comprehensive Cancer Center, 11100 Euclid Avenue, Cleveland, Ohio 44106-5061, USA. Telephone: 216-844-4766; Fax: 216-844-3616; e-mail: mjl13{at}po.cwru.edu

Allogeneic transplantation with umbilical cord blood (UCB) is limited in adult recipients by a low CD34+ cell dose. Clinical trials incorporating cytokine-based UCB in vitro expansion have not demonstrated significant shortening of hematologic recovery despite substantial increases in CD34+ cell dose, suggesting loss of stem cell function. To sustain stem cell function during cytokine-based in vitro expansion, a feeder layer of human mesenchymal stem cells (MSCs) was incorporated in an attempt to mimic the stem cell niche in the marrow microenvironment. UCB expansion on MSCs resulted in a 7.7-fold increase in total LTC-IC output and a 3.8-fold increase of total early CD34+ progenitors (CD38-/HLA-DR-). Importantly, early CD34+/CD38-/HLA-DR- progenitors from cultures expanded on MSCs demonstrated higher cytoplasmic expression of the cell-cycle inhibitor, p21cip1/waf1, and the antiapoptotic protein, BCL-2, compared with UCB expanded in cytokines alone, suggesting improved maintenance of stem cell function in the presence of MSCs. Moreover, the presence of MSCs did not elicit UCB lymphocyte activation. Taken together, these results strongly suggest that the addition of MSCs as a feeder layer provides improved conditions for expansion of early UCB CD34+/CD38-/HLA-DR- hematopoietic progenitors and may serve to inhibit their differentiation and rates of apoptosis during short-term in vitro expansion.




This article has been cited by other articles:


Home page
Stem CellsHome page
M. L. Weiss, C. Anderson, S. Medicetty, K. B. Seshareddy, R. J. Weiss, I. VanderWerff, D. Troyer, and K. R. McIntosh
Immune Properties of Human Umbilical Cord Wharton's Jelly-Derived Cells
Stem Cells, November 1, 2008; 26(11): 2865 - 2874.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
W. Wagner, C. Roderburg, F. Wein, A. Diehlmann, M. Frankhauser, R. Schubert, V. Eckstein, and A. D. Ho
Molecular and Secretory Profiles of Human Mesenchymal Stromal Cells and Their Abilities to Maintain Primitive Hematopoietic Progenitors
Stem Cells, October 1, 2007; 25(10): 2638 - 2647.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Pevsner-Fischer, V. Morad, M. Cohen-Sfady, L. Rousso-Noori, A. Zanin-Zhorov, S. Cohen, I. R. Cohen, and D. Zipori
Toll-like receptors and their ligands control mesenchymal stem cell functions
Blood, February 15, 2007; 109(4): 1422 - 1432.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
Z. Guo, H. Li, X. Li, X. Yu, H. Wang, P. Tang, and N. Mao
In Vitro Characteristics and In Vivo Immunosuppressive Activity of Compact Bone-Derived Murine Mesenchymal Progenitor Cells
Stem Cells, April 1, 2006; 24(4): 992 - 1000.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
W. Wagner, R. Saffrich, U. Wirkner, V. Eckstein, J. Blake, A. Ansorge, C. Schwager, F. Wein, K. Miesala, W. Ansorge, et al.
Hematopoietic Progenitor Cells and Cellular Microenvironment: Behavioral and Molecular Changes upon Interaction
Stem Cells, September 1, 2005; 23(8): 1180 - 1191.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
W. Tse and M. J. Laughlin
Umbilical Cord Blood Transplantation: A New Alternative Option
Hematology, January 1, 2005; 2005(1): 377 - 383.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
S. Sun, Z. Guo, X. Xiao, B. Liu, X. Liu, P.-H. Tang, and N. Mao
Isolation of Mouse Marrow Mesenchymal Progenitors by a Novel and Reliable Method
Stem Cells, September 1, 2003; 21(5): 527 - 535.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.stemcellsportal.com/
Copyright © 2002 by AlphaMed Press.